Temodar Alternatives Compared
| Temodar | Temozolomide | Procarbazine |
|
|---|
| Temodar (temozolomide) | Temozolomide | Procarbazine |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Glioblastoma Multiforme, Anaplastic Astrocytoma. Temodar may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Melanoma, Melanoma - Metastatic. temozolomide may also be used for purposes not listed in this medication guide. View more |
Prescription only
Prescribed for Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Glioblastoma Multiforme, Hodgkin's Lymphoma. procarbazine may also be used for purposes not listed in this medication guide. |
Related suggestions Glioblastoma Multiforme
Anaplastic Astrocytoma
Popular comparisons
|
|||||||
| More about Temodar (temozolomide) | More about Temozolomide | More about Procarbazine | ||||||||
| Ratings & Reviews | ||||||||||
|
Temodar has an average rating of 8.1 out of 10 from a total of 7 ratings on Drugs.com. 86% of reviewers reported a positive effect, while 14% reported a negative effect. |
Temozolomide has an average rating of 8.6 out of 10 from a total of 10 ratings on Drugs.com. 90% of reviewers reported a positive effect, while 10% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
|
See also: Temodar side effects in more detail. |
See also: temozolomide side effects in more detail. |
See also: procarbazine side effects in more detail. |
||||||||
| Generic Availability | ||||||||||
|
Lower cost generic |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all temozolomide prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
|
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
Temodar | Matulane | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
1.8 hours |
1.8 hours |
84 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 256 drugs are known to interact with Temodar:
|
A total of 256 drugs are known to interact with temozolomide:
|
A total of 526 drugs are known to interact with procarbazine:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
August 11, 1999 |
August 11, 1999 |
July 22, 1969 |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.